Longeveron LGVN
NASDAQ LGVN
$2.59 -0.10 (-3.72%)
At close: Oct 1, 2026 · 4:00 PM EDT

Longeveron (LGVN) Revenue (2020 - 2026)

Updated

Longeveron's Revenue was $287,000 in Q2 2026, down 9.2% from $316,000 a year earlier and down 27.9% from the prior quarter.

Analysis

Longeveron (LGVN) Revenue (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Longeveron's Revenue was $1.19 million through Jun 30, 2026, down 42.7% year-over-year; for FY2025, it was $1.2 million, down 49.9% from FY2024.

  • Revenue shows a five-year compound annual growth rate of -26.6% (FY2020 to FY2025).
  • In earlier years, Revenue was $2.39 million in FY2024 (+237.4%), $709,000 in FY2023 (-42.0%), $1.22 million in FY2022 (-6.4%) and $1.31 million in FY2021 (-76.8%).
  • Quarterly Revenue has moved between $63,000 (Q4 2023) and $773,000 (Q3 2024) over five years.
  • Compared with a year earlier, Revenue was higher in three of the last eight quarters, with growth averaging 135.4%.
  • The best year-over-year quarter for Revenue over five years was Q4 2024 (growth of 857.1%); the worst was Q3 2021 (a decline of 87.6%).
  • Per Business Quant data, LGVN's Revenue in the three quarters before Q2 2026 was $398,000 (Q1 2026), $365,000 (Q4 2025) and $137,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Longeveron 8.14 Mn -31.66 Mn 182,000.00 287,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 287,000.00
Mar 31, 2026 398,000.00
Dec 31, 2025 365,000.00
Sep 30, 2025 137,000.00
Jun 30, 2025 316,000.00
Mar 31, 2025 381,000.00
Dec 31, 2024 603,000.00
Sep 30, 2024 773,000.00
Jun 30, 2024 468,000.00
Mar 31, 2024 548,000.00
Dec 31, 2023 63,000.00
Sep 30, 2023 150,000.00
Jun 30, 2023 217,000.00
Mar 31, 2023 279,000.00
Dec 31, 2022 121,000.00
Sep 30, 2022 265,000.00
Jun 30, 2022 466,000.00
Mar 31, 2022 370,000.00
Dec 31, 2021 209,000.00
Sep 30, 2021 232,000.00
API Access

Longeveron Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=LGVN&period=max&api_key=YOUR_API_KEY